Alzamed Neuro (ALZN) Stock Flies On Alzheimer’s Data

Alzamed Neuro ALZN Stock News

Alzamend Neuro Inc (NASDAQ: ALZN) is screaming for the top in the market this morning, and for good reason. The company announced positive results surrounding an experimental therapy for patients with Alzheimer’s disease.  Here’s the scoop.  Stop wasting your time! Start finding winning trades in minutes with Trade Ideas! ALZN Announces Positive Alzheimer’s Data In … Read more

NeuroMetrix (NURO) Stock Continues Skyward | Here’s Why

NeuroMetrix NURO Stock News

NeuroMetrix, Inc. (Nasdaq: NURO) is screaming for the top in the premarket hours, following up on the massive gains seen in the stock yesterday. The gains started when the company announced that it has received FDA Breakthrough Designation for its Quell device. Here’s what’s happening, and why this news is so significant:  Stop wasting your … Read more

Ardelyx (ARDX) Stock Is Tumbling On FDA News

Ardelyx ARDX Stock News

Ardelyx Inc (NASDAQ: ARDX) is taking a dive in the market this morning with the stock down more than 70% in the premarket as a result of sobering news from the FDA. Unfortunately, there’s a problem with the company’s recently submitted New Drug Application.  Here’s what’s happening: Stop wasting your time! Start finding winning trades … Read more

NRx Pharmaceuticals (NRXP) Stock Flies On COVID-19 News

NRx Pharmaceuticals NRXP Stock News

NRx Pharmaceuticals Inc (NASDAQ: NRXP) is screaming for the top in the market this morning, trading on gains of more than 70%, and for good reason. The company announced the coming presentation of positive data surrounding its potential COVID-19 treatment. Here’s what’s happening: Stop wasting your time! Start finding winning trades in minutes with Trade … Read more

Clovis Oncology (CLVS) Stock Is Gearing Up For A Short Squeeze

Clover Health Investments CLOV Stock News

Clovis Oncology Inc (NASDAQ: CLVS) is inching up in the premarket this morning, and while gains aren’t dramatic… yet… the social community is buzzing about the ticker. Ultimately, the retail crowd expects that a major short squeeze is on the horizon, which could become a self-fulfilling prophecy. Here’s what’s going on: Stop wasting your time! … Read more

Silo Pharma (SILO) Stock To Climb On Research Agreement

Silo Pharma SILO Stock News

Silo Pharma (OTCMKTS: SILO) is setting the stage for a strong start to the trading session this morning, and for good reason. The company announced that it has entered into a new research agreement. Here’s what’s going on: Stop wasting your time! Start finding winning trades in minutes with Trade Ideas! SILO Announces Research Agreement … Read more

ReShape Lifesciences (RSLS) Stock Climbs On Lap-Band News

ReShape Lifesciences RSLS Stock News

ReShape Lifesciences (NASDAQ: RSLS) is screaming for the top for yet another trading session. The gains started shortly after the company announced that it would be moving manufacturing of its Lap-Band product to the United States. Here’s what’s happening: Stop wasting your time! Start finding winning trades in minutes with Trade Ideas! RSLS Announces Lap-Band … Read more

Silo Pharma (SILO) Stock Announces Agreement Extension

Silo Pharma SILO Stock News

Silo Pharma (OTCMKTS: SILO) is set to have a strong day in the market today, and for good reason. The company announced that it has extended an exclusive option license agreement. Here’s what’s going on: Stop wasting your time! Start finding winning trades in minutes with Trade Ideas! SILO Announces Exclusive Option Agreement Extension In … Read more

Advaxis (ADXS) Stock Is Climbing On Merger News

Advaxis ADXS Stock News

Advaxis, Inc. (NASDAQ: ADXS) is screaming for the top in the market this morning, and for good reason. The company announced news that it will merge with a privately held pharmaceutical development company by the name of Biosight. Here’s what’s happening: Stop wasting your time! Start finding winning trades in minutes with Trade Ideas! ADXS … Read more

Ocuphire Pharma (OCUP) Stock Climbs On Clinical Data

Ocuphire Pharma OCUP Stock News

Ocuphire Pharma Inc (NASDAQ: OCUP) is screaming for the top in the market this morning, and for good reason. The company announced positive results from a Phase 2 clinical trial of Nyxol in combination with low-dose pilocarpine. Here’s what’s happening: Stop wasting your time! Start finding winning trades in minutes with Trade Ideas! OCUP Stock … Read more